Preeclampsia associated changes in volume density of fetoplacental vessels in Chinese women and mouse model of preeclampsia

Placenta. 2022 Apr:121:116-125. doi: 10.1016/j.placenta.2022.03.002. Epub 2022 Mar 9.

Abstract

Introduction: Preeclampsia (PE) is associated with abnormal placental vascular structure. However, the volume density of fetoplacental vessels in PE remains unclear. Additionally, manually annotated CT angiography, which is widely used to analyze placental vessels, has issues regarding inaccuracy. Thus, computer-aided CT angiography for analyzing the volume density of fetoplacental vessels would facilitate the understanding of PE pathogenesis.

Methods: We performed computer-aided CT angiography to compare differences in placentas among 17 women with PE and 34 normotensive women. The contrast ratio in CT angiography was significantly enhanced using a three-dimensional (3-D) Hessian matrix algorithm. The PE-like mouse model was established by administration of 125 mg/kg/day NG-nitro-l-arginine methyl ester (l-NAME) for 10 days. The presence of endothelial marker CD31 was confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). The expression of angiogenic factors (PlGF, VEGFA, and sFlt1) in placentas was detected using qRT-PCR and western blotting.

Results: The volume density in fetoplacental vessels and CD31 expression were significantly reduced in women with PE and l-NAME-induced mice. Additionally, the downregulation of angiogenic factors (PlGF/VEGFA) and upregulation of an anti-angiogenic factor (sFlt1) were determined in a mouse model.

Discussion: Contrast-enhanced CT angiography with the aid of a 3-D Hessian matrix algorithm was performed. PE significantly affects the formation of vascular vessels, resulting in a lower volume density of fetoplacental vessels in humans and mice. This may be explained by the abnormal release of angiogenic factors during PE.

Keywords: Angiogenic factor; CD31; Fetoplacental vessel; Placenta; Preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / metabolism
  • Animals
  • China
  • Disease Models, Animal
  • Female
  • Humans
  • Mice
  • NG-Nitroarginine Methyl Ester / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Placenta / metabolism
  • Placenta Growth Factor / metabolism
  • Pre-Eclampsia* / metabolism
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1* / metabolism

Substances

  • Angiogenesis Inducing Agents
  • Placenta Growth Factor
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • NG-Nitroarginine Methyl Ester